UP-FRONT PSMA ALLIANCE: USING THERANOSTICS EARLY TO ERADICATE PROSTATE CANCER AND DEVELOPING NOVEL STARTEGIES FOR PSMA-NEGATIVE DISEASE

| Funding period: 2019 - 2022

Active